The Week in Review: Pharmaron Raises $40 Million in Venture Capital

Pharmaron, a Beijing CRO, closed a Series C financing round totaling over $40 million to expand its offerings; Jolly Pharma completed its $71.5 million ChiNext IPO; Hisoar Pharma raised $79 million in a private placement; Sanofi-Aventis closed its $521 million acquisition of BMP Sunstone; Shanghai Pharma is reportedly close to buying a large stake in German drug distributor Celesio; the PRC plans to invest $761 million in API manufacturers to increase exports; and the US FDA plans to outsource more foreign inspections of drug manufacturers; and Biomics agreed with Benitec to advance their RNAi hepatitis B anti-viral collaboration. More details…. Stock Symbol: (SHE: 300181) (SHE: 002099) (NYSE: SNY) (SHA: 601607) (ASX: BLT)